IDSA Media Briefing: COVID-19 Therapies Lessons Learned

A media briefing from experts from the Infectious Diseases Society of America to discuss COVID-19 treatment.

• How clinical trials can be improved
• Standards needed for the FDA’s Emergency Use Authorizations
• Molnupiravir review process
• Infrastructure needed to respond to for future pandemics

FEATURING

Adarsh Bhimraj, MD, FIDSA—Cleveland, OH
Fellow—Infectious Diseases Society of America
Chair—IDSA COVID-19 Treatment and Management Guidelines Expert Panel
Head of the Neurologic Infectious Diseases Section, Department of Infectious Diseases, Cleveland Clinic
Associate Staff Physician, Department of Infectious Diseases, Cleveland Clinic

Rajesh T. Gandhi, MD, FIDSA—Boston, MA
Fellow—Infectious Diseases Society of America
Immediate Past President—HIV Medicine Association
Professor of Medicine, Harvard Medical School
Director of HIV Clinical Services and Education, Massachusetts General Hospital

Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America